Drotaverine
ALIMENTARY TRACT AND METABOLISM
Also known as: dihydroisoperparine, drotaverin, drotaverin hydrochloride, drotaverine HCl, drotaverine hydrochloride, isodihydroperparine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Drotaverine is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including PDE4B and CACNA1C.
- Molecular targets: PDE4B and CACNA1C (2 listed in DrugCentral).
- ATC code: A03AD02 (Papaverine and derivatives).
- Molecular formula: C24H31NO4; molecular weight 397.51 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE4B | unknown | — |
| Voltage-dependent L-type calcium channel subunit alpha-1C | CACNA1C | unknown | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A03AD02 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › Papaverine and derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Renal function test abnormal | 203.7 |
| Creatinine renal clearance increased | 176.6 |
| Sedation complication | 168.6 |
| Creatinine renal clearance decreased | 159.4 |
| Multiple drug therapy | 145.3 |
| Blood calcium decreased | 135.9 |
| Balance disorder | 120.2 |
| Orthostatic hypotension | 112.8 |
| Sedation | 109.1 |
| Cognitive disorder | 108.5 |
| Drug interaction | 100.7 |
| Depressed level of consciousness | 93.3 |
Chemical structure
| Molecular formula | C24H31NO4 |
|---|---|
| Molecular weight | 397.51 g/mol |
| CAS number | 14009-24-6 |
| InChIKey | OMFNSKIUKYOYRG-MOSHPQCFSA-N |
| PubChem CID | 1712095 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Drotaverine work?
Its molecular targets in DrugCentral include PDE4B and CACNA1C.
What is the chemical formula of Drotaverine?
Drotaverine has the molecular formula C24H31NO4 and a molecular weight of 397.51 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 969 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL551978 — compound record and bioactivity
- PubChem CID 1712095 — chemical identifiers
- DrugBank DB06751 — drug record
- FDA UNII 98QS4N58TW — substance identity
- UniProt Q07343 (PDE4B) — target protein
- UniProt Q13936 (CACNA1C) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.